Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 641,226	$ 1,137,303
Trade accounts receivable, less allowance for doubtful accounts (2018 – $6,300; 2017 – $10,425)	550,788	534,326
Other accounts receivable	41,961	37,937
Inventories	727,381	592,781
Other current assets	98,221	136,064
Assets held for sale	0	39,152
Total current assets	2,059,577	2,477,563
Property, plant and equipment, at cost	4,571,779	4,124,335
Less accumulated depreciation and amortization	1,746,414	1,631,025
Net property, plant and equipment	2,825,365	2,493,310
Investments	535,292	534,064
Noncurrent assets held for sale	0	139,813
Other assets	78,054	74,164
Goodwill	1,590,906	1,610,355
Other intangibles, net of amortization	398,001	421,503
Total assets	7,487,195	7,750,772
Current liabilities:
Accounts payable	474,229	418,537
Accrued expenses	258,371	268,336
Current portion of long-term debt	286,188	422,012
Dividends payable	35,462	35,165
Liabilities held for sale	0	1,938
Income taxes payable	72,759	54,937
Total current liabilities	1,127,009	1,200,925
Long-term debt	1,411,605	1,415,360
Postretirement benefits	51,669	52,003
Pension benefits	278,682	294,611
Noncurrent liabilities held for sale	0	614
Other noncurrent liabilities	553,469	599,174
Deferred income taxes	378,484	370,389
Commitments and contingencies (Note 9)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 106,187 in 2018 and 110,547 in 2017	1,062	1,105
Additional paid-in capital	1,363,262	1,863,949
Accumulated other comprehensive loss	(314,191)	(225,668)
Retained earnings	2,478,711	2,035,163
Total Albemarle Corporation shareholders’ equity	3,528,844	3,674,549
Noncontrolling interests	157,433	143,147
Total equity	3,686,277	3,817,696
Total liabilities and equity	$ 7,487,195	$ 7,750,772